MBL Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Buy
2,439
+17
+0.7% +$17.4K 0.2% 76
2026
Q1
$2.23M Buy
2,422
+145
+6% +$147K 0.17% 77
2025
Q4
$2.45M Buy
2,277
+766
+51% +$732K 0.2% 73
2025
Q3
$1.15M Sell
1,511
-100
-6% -$74.4K 0.1% 101
2025
Q2
$1.26M Buy
1,611
+53
+3% +$41.2K 0.12% 90
2025
Q1
$1.29M Buy
1,558
+152
+11% +$126K 0.13% 79
2024
Q4
$1.09M Sell
1,406
-28
-2% -$23.2K 0.11% 90
2024
Q3
$1.27M Buy
1,434
+45
+3% +$40.5K 0.14% 79
2024
Q2
$1.26M Buy
1,389
+33
+2% +$26.4K 0.14% 76
2024
Q1
$1.05M Buy
1,356
+3
+0.2% +$2.13K 0.12% 84
2023
Q4
$789K Buy
1,353
+6
+0.4% +$3.5K 0.1% 94
2023
Q3
$724K Buy
1,347
+66
+5% +$34K 0.1% 94
2023
Q2
$601K Buy
1,281
+402
+46% +$169K 0.08% 100
2023
Q1
$302K Sell
879
-2
-0.2% -$675 0.05% 126
2022
Q4
$322K Buy
881
+71
+9% +$25.2K 0.06% 126
2022
Q3
$262K Buy
810
+68
+9% +$21.5K 0.06% 129
2022
Q2
$241K Buy
742
+3
+0.4% +$901 0.06% 121
2022
Q1
$212K Buy
+739
New +$190K 0.05% 159

Other funds holding LLY

MBL Wealth's LLY Position: Q2 2026 in Review

MBL Wealth increased its Eli Lilly (LLY) stake by 0.7% in Q2 2026, buying an estimated $17.4K and bringing the position to 2,439 shares worth $2.93M. The position accounts for 0.2% of the portfolio, ranked #76.

MBL Wealth first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MBL Wealth held 2,439 shares of Eli Lilly worth $2.93M as of Q2 2026.
  • MBL Wealth bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.2% of MBL Wealth's portfolio in Q2 2026, its #76 holding.
  • MBL Wealth first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.